Essential role of leukotriene B4 on Leishmania (Viannia) braziliensis killing by human macrophages

Microbes and Infection

Volumn 16, Issue 11, 2014, Pages 945-953

  Morato, Camila I ^a   da Silva, Ildefonso A ^a   Borges, Arissa F ^a   Dorta, Miriam L ^a   Oliveira, Milton A P ^a   Jancar, Sonia ^b   Serezani, Carlos H ^c   Ribeiro Dias, Fátima ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human; Leishmania (V.) braziliensis; LTB4; Macrophage; ROS

Indexed keywords

LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR 1 ANTAGONIST; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; LEUKOTRIENE B4 RECEPTOR; LTB4R PROTEIN, HUMAN;

ARTICLE; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; MACROPHAGE; MACROPHAGE CULTURE; MACROPHAGE FUNCTION; MONOCYTE; PARACRINE SIGNALING; PARASITE ISOLATION; PARASITE LOAD; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

LEISHMANIA BRAZILIENSIS;

CELL SURVIVAL; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMANS; LEISHMANIA BRAZILIENSIS; LEUKOTRIENE B4; MACROPHAGES; REACTIVE OXYGEN SPECIES; RECEPTORS, LEUKOTRIENE B4;

EID: 84919472098     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.08.015     Document Type: Article

References (38)

1. Convit J., Ulrich M., Fernández C.T., Tapia F.J., Cáceres-Dittmar G., Castés M., et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993, 87:444-448.
2. Goto H., Lauletta Lindoso J.A. Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin North Am 2012, 26:293-307.
3. Carvalho L.P., Passos S., Schriefer A., Carvalho E.M. Protective and pathologic immune responses in human tegumentary leishmaniasis. Front Immunol 2012, 3:301.
4. de Oliveira C.I., Brodskyn C.I. The immunobiology of Leishmania braziliensis infection. Front Immunol 2012, 3:145.
5. Giudice A., Vendrame C., Bezerra C., Carvalho L.P., Delavechia T., Carvalho E.M., et al. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis 2012, 12:75.
6. Peres C.M., de Paula L., Medeiros A.I., Sorgi C.A., Soares E.G., Carlos D., et al. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes Infect 2007, 9:483-489.
7. 4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes. J Immunol 2013, 190:1614-1622.
8. 4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect Immun 2002, 70:4247-4253.
9. Serezani C.H., Perrela J.H., Russo M., Peters-Golden M., Jancar S. Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J Immunol 2006, 177:3201-3208.
10. Machado E.R., Ueta M.T., Lourenço E.V., Anibal F.F., Sorgi C.A., Soares E.G., et al. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J Immunol 2005, 175:3892-3899.
11. 4 induces release of antimicrobial peptides in lungs of virally infected mice. J Immunol 2008, 180:6211-6221.
12. 4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun 2001, 69:2011-2016.
13. 4 to humans. J Infect Dis 2004, 189:2001-2009.
14. 4 receptors: novel roles in immunological regulations. Adv Enzyme Regul 2011, 51:59-64.
15. Reiner N.E., Malemud C.J. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: invitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. J Immunol 1985, 134:556-563.
16. Lefèvre L., Lugo-Villarino G., Meunier E., Valentin A., Olagnier D., Authier H., et al. The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum. Immunity 2013, 38:1038-1049.
17. Zauli-Nascimento R.C., Miguel D.C., Yokoyama-Yasunaka J.K.U., Pereira L.I.A., Pelli de Oliveira M.A., Ribeiro-Dias F., et al. Invitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Trop Med Int Heal 2010, 15:68-76.
18. 2 and EDTA. J Immunol Methods 2000, 241:121-129.
19. 4 via a GM-CSF/PU.1 axis. J Immunol 2012, 189:906-915.
20. Muniz-Junqueira M.I., de Paula-Coelho V.N. Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, invitro. Int Immunopharmacol 2008, 8:1633-1638.
21. Serezani C.H.C., Aronoff D.M., Jancar S., Mancuso P., Peters-Golden M. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 2005, 106:1067-1075.
22. 4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. J Immunol 2003, 170:6273-6279.
23. Ogunkolade B.W., Colomb-Valet I., Monjour L., Rhodes-Feuillette A., Abita J.P., Frommel D. Interactions between the human monocytic leukaemia THP-1 cell line and old and new world species of Leishmania. Acta Trop 1990, 47:171-176.
24. Khouri R., Bafica A., Silva M.P., Noronha A., Kolb J.-P., Wietzerbin J., et al. IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol 2009, 182:2525-2531.
25. Coffey M.J., Phare S.M., Cinti S., Peters-Golden M., Kazanjian P.H. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocytes and neutrophils in acquired immunodeficiency syndrome. Blood 1999, 94:3897-3905.
26. + channels. Eur Respir J 2009, 33:1105-1112.
27. 4 mediates p47phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils. J Leukoc Biol 2005, 78:976-984.
28. Morato-Marques M., Campos M.R., Kane S., Rangel A.P., Lewis C., Ballinger M.N., et al. Leukotrienes target F-actin/cofilin-1 to enhance alveolar macrophage anti-fungal activity. J Biol Chem 2011, 286:28902-28913.
29. Secatto A., Rodrigues L.C., Serezani C.H., Ramos S.G., Dias-Baruffi M., Faccioli L.H., et al. 5-Lipoxygenase deficiency impairs innate and adaptive immune responses during fungal infection. PLoS One 2012, 7:e31701.
30. Serezani C.H., Aronoff D.M., Sitrin R.G., Peters-Golden M. FcgammaRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions. Blood 2009, 114:3316-3324.
31. Cho K.J., Seo J.M., Kim J.H. Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species. Mol Cells 2011, 32:1-5.
32. Murray H.W., Cartelli D.M. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest 1983, 72:32-44.
33. Murray H.W. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med 1981, 153:1302-1315.
34. 4 enhances pulmonary host defense against pneumococcal pneumonia. Infect Immun 2010, 78:2264-2271.
35. 2-linked cascade. J Biol Chem 2000, 275:32357-32362.
36. 4 stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 2002, 277:8572-8578.
37. Rocha F.J.S., Schleicher U., Mattner J., Alber G., Bogdan C. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect Immun 2007, 75:3823-3832.
38. Murray H.W., Nathan C.F. Macrophage microbicidal mechanisms invivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 1999, 189:741-746.